Interference of NF-κB function through IKK inhibition is expected to suppress NF-κB protein translocation to the nucleus and is considered a promising strategy for disease treatment, especially against inflammation and inflammation-related cancer [144,145,146]. The gene discussed is NFKB1; the disease is cancer.